Svetlana Mosteoru

316 posts

Svetlana Mosteoru

Svetlana Mosteoru

@SMosteoru

Cardiologist passionate about research

Timişoara, România Katılım Eylül 2018
168 Takip Edilen195 Takipçiler
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
Living in 🌳 and 🏞️ environment is associated with lower incidence of heart failure 💔 Learn more about the best living space for your 💓 👉 doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
1
15
27
2.3K
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
Elevated Lp(a) contribute to increased levels of low-density lipoprotein cholesterol in 🧒 with 👨‍👩‍👧‍👦 hypercholesterolemia. Explore more in the link 👉 doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
0
25
48
3.1K
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
💊 Bempedoic acid reduced MACE4 risk, with an additional benefit in patients with elevated steatosis scores 👉 doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
2
28
70
6.9K
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
💪 High intensity interval aerobic excercise (HIIE) has shown superior efficacy over moderate continuous exercise in enhancing endothelial function. A progressive training strategy is recommended to maximise long-term results. Check this meta-analysis👉doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
5
52
182
125.3K
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
🦠 Giant cell arteritis significantly increases risk of vascular complications 📢 Do we need cardiovascular risk management and inflammation control strategies? Check this new article 👉 doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
0
10
13
623
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
Young adults with VTE have an elevated risk of CVD compared with persons in an age- and sex-matched comparison cohort - 📢 results from a Danish nationwide cohort 👉doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
1
6
14
1.1K
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
Are there new biomarkers able to predict new-onset AF? 🫀NT-proBNP and others not yet incorporated into clinical practice, such as Lp(a) and sVCAM-1, could play a role in the diagnosis and preventive management of AF 👉doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
0
13
29
938
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
🩸🫘Elevated IL-6 predicts greater long-term eGFR decline, worsening albuminuria, and higher CKD risk Check this article 👉doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
4
45
118
6.8K
Svetlana Mosteoru retweetledi
European Atherosclerosis Society
In this episode of AtheroTalk, we discuss with Prof. Gerald F. Watts, a leading world expert in the field of Familial Hypercholesterolemia (FH) and Cardio-metabolic Medicine, about his professional journey, about national strategies and policies in FH and about how can young professionals achieve a successful career. Prof. Watts shares his insights about the process of adding clinical meaning into research projects, his mentors and overcoming challenges. He also shares ways to address gaps in care, a fresh perspective on cardiometabolic prevention, methods of thinking and ideas that help researchers keep their research relevant. Tune in and don’t miss the powerful motto that Prof. Watts has followed throughout his exceptional career – “discovery comes to the prepared mind”. 🎧 Spotify: eas.to/ATHTalkE27S 🎧 Apple Podcasts: eas.to/ATHTalkE27A 🎧 Youtube: eas.to/ATHTalkE27Y
European Atherosclerosis Society tweet media
English
0
1
9
230
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
Icosapent ethyl was associated with fewer hospitalizations and increased the chances of an individual living without hospitalization 🏥 Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT 👉doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
2
12
22
1.5K
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
Body roundness index (BRI) can predict CV mortality better than BMI ❤️ Higher BRI is independently associated with increased cardiovascular mortality, particularly among middle aged adults and those with normal BMI 👉doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
0
12
21
1.2K
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
Haptoglobin (HP) & CVD risk in Type 2 diabetes 🧬 Higher baseline HP levels especially with the HP 1-1 phenotype are linked to greater CVD risk. Fenofibrate’s CV benefit, however, is unchanged by HP phenotype or levels. 👉 doi.org/10.1093/eurjpc…
EJPC Editor-in-Chief tweet media
English
0
7
22
812
Svetlana Mosteoru retweetledi
EJPC Editor-in-Chief
EJPC Editor-in-Chief@EJPCEiC·
🫀🧠 1 in 6 patients admitted with MI or stroke get a new diabetes diagnosis unchanged for 30 years. 🔍 Detection is higher with OGTT vs HbA1c alone. 💬 Should diabetes screening after MI/stroke be standardized? 👇 What’s the main barrier? #preventivecardiology
EJPC Editor-in-Chief tweet media
English
0
16
22
1.3K
Svetlana Mosteoru retweetledi
EAPCPresident
EAPCPresident@EAPCPresident·
Happy New Year to our wonderful EAPC community! 🌟 As we step into 2026, I wish you all a year filled with purpose, health, and success. We have an exciting year ahead, packed with ambitious projects and new challenges in our mission to advance preventive cardiology. Let’s continue working together to protect hearts across Europe and beyond. 🫀✨ #PreventiveCardiology @escardio
English
1
7
12
841